Accueil
Détail de l'auteur
Auteur C. REIBER |
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheAbuse and violence history of men and women in treatment for methamphetamine dependence / J. B. COHEN
Titre : Abuse and violence history of men and women in treatment for methamphetamine dependence Titre traduit : (Passé de violence et d'abus chez des hommes et des femmes en traitement pour des problèmes de dépendance aux methamphétamines) Type de document : Périodique Auteurs : J. B. COHEN ; A. DICKOW ; K. HORNER ; J. E. ZWEBEN ; J. BALABIS ; D. VANDERSLOOT ; C. REIBER ; METHAMPHETAMINE TREATMENT PROJECT Année de publication : 2003 Importance : 377-385 Présentation : tabl. Note générale : Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE
METHAMPHETAMINE ; ABUS ; DEPENDANCE ; ETUDE TRANSVERSALE ; VIOLENCE ; SEXE ; TRAITEMENT ; CLASSIFICATION ; ABUS SEXUEL ; TRAJECTOIRE ; USAGER
Thésaurus Géographique
ETATS-UNISDiscipline : EPI Epidémiologie / Epidemiology Résumé : The Methamphetamine Treatment Project offers the opportunity to examine the history of abuse and violence in a sample of 1016 methamphetamine users participating in a multisite study between 1999-2001. Reporting of abuse and violence was extensive, with 80% of women reporting abuse or violence from a partner. Men were more likely to report experiencing violence from friends and others. A high percentage of study participants reported a variety of threatening or coercive experiences with their partners. Past and current interpersonal violence is a characteristic of the lifestyles of the majority entering treatment for methamphetamine dependence. (Review' s abstract) Domaine : Drogues illicites / Illicit drugs Refs biblio. : 48 Affiliation : East Bay Community Recovery Project, Oakland, CA
Etats-Unis. United States.Numéro Toxibase : 207123 Centre Emetteur : 02 Coordonnateur Cote : A01577 Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=57401 Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience / L. AMASS in American Journal on Addictions, Vol.13, Suppl.1 (May-June 2004)
Titre : Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience Titre traduit : (Mettre en place la désintoxication à la buprénorphine-naloxone dans les services de traitement communautaires : l'expérience conduite par le NIDA au sein du Clinical Trial Network) Type de document : Périodique Auteurs : L. AMASS ; W. LING ; T. E. FREESE ; C. REIBER ; J. J. ANNON ; A. J. COHEN ; D. McCARTY ; M. S. REID ; L. S. Jr BROWN ; C. CLARK ; ZIEDONIS D. M. ; J. KREJCI ; STINE S. ; T. WINHUSEN ; G. BRIGHAM ; D. BABCOCK ; MUIR J. A. ; B. J. BUCHAN ; T. HORTON Année de publication : 2004 Article en page(s) : S42-S66 Présentation : graph. ; tabl. Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE
CURE DE DESINTOXICATION ; OPIACES ; BUPRENORPHINE ; NALOXONE ; EFFICACITE ; ETUDE TRANSVERSALE
Thésaurus Géographique
ETATS-UNISDiscipline : TRA Traitement et prise en charge / Treatment and care Résumé : In October 2002, the US Food and Drug Administration approved buprenorphine-naloxone (Suboxone) sublingual tablets as an opioid dependence treatment available for use outside traditionally licensed opioid treatment programs. The NIDA Center for Clinical Trials Network (CTN) sponsored two clinical trials assessing buprenorphine-naloxone for short term opioid detoxification. These trials provided an unprecedented field test of its use in twelve diverse community-based treatment programs. Opioid dependent men and women were randomized to a thirteen-day buprenorphine-naloxone taper regimen, for short term opioid detoxification. The 234 buprenorpbine-naloxone patients averaged 37 years old and used mostly intravenous heroin. Direct and rapid induction onto buprenorphine-naloxone was safe and well tolerated. Most patients (83%) received 8 mg buprenorphine - 2 mg naloxone on the first day and 90% successfully completed induction and reached a target dose of 16mg buprenorphine - 4 mg naloxone in three days. Medication compliance and treatment engagement was high. An average of 81 % of available doses was ingested, and 68% of patients completed the detoxification. Most (80.3%) patients received some ancillary medications with an average of 2.3 withdrawal symptoms treated. The safety profile of buprenorphine-naloxone was excellent. Of eighteen serious adverse events reported, only one was possibly related to buprenorphine-naloxone. All providers successfully integrated buprenorphine-naloxone into their existing treatment milieus. Overall, data from the CTN field exerience suggest that buprenorphine-naloxone is practical and safe for use in diverse community treatment settings, including those with minimal experience providing opioid based pharmacotherapy and/or medical detoxification for opioid dependence. Domaine : Drogues illicites / Illicit drugs Refs biblio. : 90 Affiliation : NIDA's National Drug Abuse Treatment Clinical Trials Network (CTN), including the Friends Research Institute, Inc., Los Angeles, Calif./Pacific Region Node, USA Numéro Toxibase : 207451 Centre Emetteur : 02 Coordonnateur Cote : Abonnement Lien : http://dx.doi.org/10.1080/10550490490440807 Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=18378
in American Journal on Addictions > Vol.13, Suppl.1 (May-June 2004) . - S42-S66[article]
Titre : A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence Titre traduit : (Comparaison entre les approches de gestion des éventualités et les approches cognitivo-comportementales pendant un traitement de maintenance à la méthadone pour dépendance à la cocaïne) Type de document : Périodique Auteurs : R. A. RAWSON ; A. HUBER ; M. McCANN ; S. SHOPTAW ; D. FARABEE ; C. REIBER ; W. LING Année de publication : 2002 Importance : 817-824 Note générale : Archives of General Psychiatry, 2002, 59, (9), 817-824 Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE
COMPARAISON ; THERAPIE COGNITIVO-COMPORTEMENTALE ; TRAITEMENT DE MAINTENANCE ; METHADONE ; COCAINE
Thésaurus Géographique
ETATS-UNISDiscipline : TRA Traitement et prise en charge / Treatment and care Résumé : FRANÇAIS :
L'objet de l'étude relatée dans cet article est de comparer l'efficacité des deux modes d'approches du traitement de la dépendance à la cocaïne chez des patients sous maintenance à la méthadone et d'explorer si les réductions de consommation se poursuivent après le traitement. L'hypothèse est que tous les traitements ont pour conséquence la réduction de consommation. Cependant on note que la maintenance sous méthadone seule ne diminue pas l'usage, que la gestion d'éventualités est plus opérante sur la réduction de la consommation au cours du traitement, que l'approche cognitivo-comportementale entraîne une baisse des consommations encore après le traitement. De plus il est montré que les trois approches combinées ont de meilleurs résultats qu'une seule d'entre elles.
ENGLISH :
Background: This study compared 2 psychosocial approaches for the treatment of cocaine dependence: contingence management (CM) and cognitive-behavioral therapy (CBT). Methods: Patients with cocaine dependence who were receiving methadone maintenance treatment (n = 120) were randomly assigned to 1 of 4 conditions: CM, CBT, combined CM and CBT (CBT + CM), or treatment as usual (ie, methadone maintenance treatment program only [MMTP only]) (n = 30 per cell). The CM procedures and CBT materials were comparable to those used in previously published research. The active study period was 16 weeks, requiring 3 clinic visits per week. Participants were evaluated during treatment and at 17, 26, and 52 weeks after admission. Results: Urinalysis results during the 16-week treatment period show that participants assigned to the 2 groups featuring CM had significantly superior in-treatment urinalysis results, whereas urinalysis results from participants in the CBT group were not significantly different than those from the MMTP-only group. At week 17, self-reported days of cocaine use were significantly reduced from baseline levels for all 3 treatment groups but not for the MMTP-only group. At the 26-week and 52-week follow-up points, CBT participants showed substantiel improvement, resulting in équivalent performance with the CM groups as indicated by both urinalysis and self-reported cocaine use data. Conclusions: Study findings provide solid evidence of efficacy for CM and CBT. Although the effect of CM is significantly greater during treatment, CBT appears to produce comparable long-term outcomes. There was no evidence of an additive effect for the 2 treatments in the CM + CBT group. (Author' s abstract)Domaine : Drogues illicites / Illicit drugs Refs biblio. : 32 Affiliation : Integrated Substance Abuse programs, Univ. California, 11075 Santa Monica Blvd, Los Angeles, 90025
Etats-Unis. United States.Numéro Toxibase : 505510 Centre Emetteur : 05 Marmottan Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=23202
Titre : A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals Titre traduit : (Une comparaison entre les traitements la dépendance aux stimulants fondés sur la gestion des contingences et les thérapies cognitivo-comportementales.) Type de document : Périodique Auteurs : R. A. RAWSON ; M. J. MCCANN ; F. FLAMMINO ; S. SHOPTAW ; K. MIOTTO ; C. REIBER ; W. LING Année de publication : 2006 Importance : 267-274 Présentation : fig. Note générale : Addiction, 2006, 101, (2), 267-274 Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE
TRAITEMENT ; COCAINE ; METHAMPHETAMINE ; COMPARAISON ; EFFICACITE ; THERAPIE COGNITIVO-COMPORTEMENTALE ; MOTIVATION ; ABSTINENCEDiscipline : TRA Traitement et prise en charge / Treatment and care Résumé : Aims: Previous research has reported that both contingency management (CM) and cognitive-behavioral therapy (CBT) are efficacious interventions for the treatment of stimulant abusers. The present study sought to directly compare the effectiveness of (CM) and (CBT) alone and in combination in reducing stimulant use. Design: Randomized clinical trial. Participants: Stimulant-dependent individuals (n = 171). Intervention: CM, CBT or combined CM and CBT, 16-week treatment conditions. CM condition participants received vouchers for stimulant-free urine samples. CBT condition participants attended three 90-minute group sessions each week. Measurements: Participants were interviewed at baseline and weeks 17, 26 and 52. Measures included psychiatric disorders and alcohol and drug use and concomitant social problems. Findings: CM procedures produced better retention and lower rates of stimulant use during the study period. Self-reported stimulant use was reduced from baseline levels at all follow-up points for all groups and urinalysis data did not differ between groups at follow-up. While CM produced robust evidence of efficacy during treatment application, CBT produced comparable longer-term outcomes. There was no evidence of an additive effect when the two treatments were combined. Conclusions: This study suggests that CM is an efficacious treatment for reducing stimulant use and is superior during treatment to a CBT approach. CM is useful in engaging substance abusers, retaining them in treatment and helping them achieve abstinence from stimulant use. CBT also reduces drug use from baseline levels and produces comparable outcomes on all measures at follow-up. (Review' s abstract) Domaine : Drogues illicites / Illicit drugs Refs biblio. : 34 Affiliation : UCLA ISAP, 1640 S. Sepulveda Blvd, Suite 200, Los Angeles, CA 90025
Etats-Unis. United States.Numéro Toxibase : 208797 Centre Emetteur : 02 Coordonnateur Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=14716
Titre : Drugs and sexual effects : role of drug type and gender Titre traduit : (Drogues et effets sur la sexualité : rôle du type de drogue selon le sexe) Type de document : Périodique Auteurs : R. A. RAWSON ; A. WASHTON ; C. P. DOMIER ; C. REIBER Année de publication : 2002 Importance : 103-108 Présentation : graph. ; tabl. Note générale : Journal of Substance Abuse Treatment, 2002, 22, (2), 103-108 Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE
SEXUALITE ; COMPORTEMENT ; CONSOMMATION ; CONDUITE A RISQUE ; EPIDEMIOLOGIE DESCRIPTIVE
Thésaurus Géographique
ETATS-UNISDiscipline : EPI Epidémiologie / Epidemiology Résumé :
ENGLISH :
This study investigated gender differences in the relationship between psychoactive substance use and sexual thoughts, feelings, and behaviors. Participants (N = 464) were male and female alcohol, opiate, cocaine, and methamphetamine users enrolled in an outpatient treatment program at any of 8 sites. A self-report survey that inquired about the specific sexual thoughts, feelings, and behaviors of the participant during previous instances of being under the influence of their primary drug of dependence served as the data source. The results indicate that different categories of psychoactive agents were associated with different effects on sexual behavior, and that those effects vary by gender. Development of a valid measure assessing the type and strength of these relationships may be beneficial for use by treatment programs in promoting abstinence from drug and alcohol use and preventing relapse. (Editor's abstract.)Note de contenu : graph. ; tabl. Domaine : Drogues illicites / Illicit drugs Refs biblio. : 22 Affiliation : UCLA Integrated Substance Abuse Pgrs, 11050 Santa Monica blvd, suite 100, Los Angeles, CA 90025. E-mail : matrixex@ucla.edu
Etats-Unis. United States.Numéro Toxibase : 403825 Centre Emetteur : 04 CIRDD-51 Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=23029 PermalinkPermalinkPermalinkPermalinkPermalink
